According to a recent study, mitochondrial ACOT9 promotes substrate biosynthesis for lipogenesis and hepatic glucose production through directing acetyl-CoA toward the citric acid cycle, thereby aggravating non-alcoholic fatty liver disease (Steensels et al., 2020). This evidence concerns the gene ACOT9 and metabolic dysfunction-associated steatotic liver disease.